COVID-19 UPDATES AS ON 22.3.2021

 

Ministry of Health and Family Welfare

Maharashtra, Punjab, Karnataka, Gujaratand Madhya Pradesh account for more than 80% of the daily new COVID19 cases

Over 4.5 cr vaccine doses administered across the country

Cumulative Fatality Rate dips to 1.37%

Posted On: 22 MAR 2021 11:12AM by PIB Delhi

 

Maharashtra, Punjab, Karnataka, Gujarat and Madhya Pradesh are reporting a surge in the COVID daily new cases. They together account for 80.5% of the total new cases registered in the last 24 hours.

46,951 new cases were registered in the last 24 hours. Of these, 84.49% are reported from 6 States of Maharashtra, Punjab, Kerala, Karnataka, Gujaratand Madhya Pradesh

Maharashtra has reported the highest daily new cases at 30,535 (65.03%). This is followed by Punjabwith 2,644 while Kerala reported 1,875 new cases. 

Eight states, as outlined under, are displaying an upward trajectory in the daily new COVID19 cases.

The graph below shows the total tests conducted and the respective cumulative positivity rates of the eight focus states. 

India’s total Active Caseload has reached 3,34,646 today. India’s present active caseload now stands at 2.87% of India’s total Positive Cases. A net incline of 25,559 cases has been added to the total active caseload in the last 24 hours.

The Daily Positivity Rate (7-day average) currently stands at 3.70%. 

Eight States/UTs have a weekly positivity rate more than the national average.

On the other hand, the total vaccination coverage in Indiahas crossed the 4.5-crore mark.

More than 4.50 cr (4,50,65,998) vaccine doses have been administered through 7,33,597 sessions, as per the provisional report till 7 am today. These include 77,86,205 HCWs (1st dose), 48,81,954 HCWs (2nd dose), 80,95,711 FLWs (1^st dose) and 26,09,742 FLWs (2^nd Dose), 37,21,455 beneficiaries aged more than 45 years with specific co-morbidities and 1,79,70,931 beneficiaries aged more than 60 years have also received the 1^st Dose.

HCWs		FLWs		45 to <60 years with Co-morbidities	Over 60 years	Total
1st Dose	2nd Dose	1st Dose	2nd Dose	1st Dose	1st Dose
77,86,205	48,81,954	80,95,711	26,09,742	37,21,455	1,79,70,931	4,50,65,998

 As on Day-65 of the vaccination drive (21^st March, 2021), total 4,62,157 vaccine doses were given. As it was a Sunday, many States and UTs did not schedule vaccination sessions.

Out of which, 4,49,115 beneficiaries were vaccinated across 8,459 sessions for 1^st dose (HCWs and FLWs) and 13,042 HCWs and FLWs received 2^nd dose of vaccine.

 

Date: 21st March,2021
HCWs		FLWs		45 to < 60 years with Co-morbidities	Over 60 years	Total Achievement
1stDose	2ndDose	1stDose	2nd Dose	1stDose	1stDose	1stDose	2ndDose
6,220	4,598	11,400	8,444	87,982	3,43,513	4,49,115	13,042

 

 

India’s cumulative recoveries stand at 1,11,51,468 today. The national Recovery Rate is 95.75%.

21,180 recoveries were registered in the last 24 hours.

On the other hand, 212 deaths were reported in the last 24 hours.

Six States account for 85.85%of the new deaths. Maharashtra saw the maximum casualties (99). Punjab follows with 44 daily deaths and Kerala reported13 deaths in the last 24 hours.

The Case Fatality Rate currently stands at 1.37% and is continuously declining.

Fourteen States/UTs have not reported any COVID19 deaths in the last 24 hours. These are Andhra Pradesh, Assam, Uttarakhand, Lakshadweep, Sikkim, Ladakh (UT), D&D & D&N, Meghalaya, Manipur, Tripura, Nagaland, Mizoram, A&N Islandsand Arunachal Pradesh.

 

****

MV/SJ
HFW/COVID States data/22^ndMarch2021/1

 

(Release ID: 1706531) Visitor Counter : 974

Ministry of Health and Family Welfare

Centre writes to States/UTs to Increase the Interval between two doses of COVISHIELD to 4-8 weeks based on NTAGI and NEGVAC Recommendation

Protection enhanced if the second dose of COVISHIELD is administered between 6-8 weeks

Posted On: 22 MAR 2021 3:20PM by PIB Delhi

 

In view of the emerging scientific evidence, the interval between two doses of a specific COVID-19 vaccine i.e. COVISHIELD, has been revisited by National Technical Advisory Group on Immunization (NTAGI) and subsequently by National Expert Group on Vaccine Administration for COVID-19 (NEGVAC) in its 20th meeting. During this meeting the recommendation has been revised to provide 2nd dose of COVISHIELD at 4-8 weeks’ interval after the 1st dose, instead of earlier practiced interval of 4-6 weeks. This decision of revised time interval between two doses is applicable ONLY to COVISHIELD and NOT to COVAXIN Vaccine.

In a letter written by the Union Health Secretary Shri Rajesh Bhushan to the Chief Secretaries of States/UTs today, he has noted that the Ministry of Health and Family Welfare, Government of India has accepted the recommendations of NTAGI and NEGVAC and has thereafter advised the States and UTs to ensure the administration of 2nd dose of COVISHIELD to beneficiaries within this stipulated time interval of 4-8 weeks after 1st dose.

Keeping the existing scientific evidence in view, it appears that protection is enhanced if the second dose of COVISHIELD is administered between 6-8 weeks, but not later than stipulated period of 8 weeks. The Union Health Secretary has urged the States and UTs to instruct the concerned officials accordingly to undertake necessary steps to widely disseminate the message of revised dosing interval amongst programme managers, vaccinators and recipients of COVISHIELD vaccine and ensure adherence of the revised dosing interval.

*****

MV/SJ

(Release ID: 1706597) Visitor Counter : 1969